Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2004
10/21/2004WO2004089987A1 Secreted polypeptide species associated with cardiovascular disorders
10/21/2004WO2004089986A1 Antimicrobial peptide from transferrin family
10/21/2004WO2004089985A1 Stable pharmaceutical compositions
10/21/2004WO2004089982A2 April variants and methods thereof
10/21/2004WO2004089981A2 Antitumor effect of mutant bik
10/21/2004WO2004089980A2 Therapeutic cancer vaccine
10/21/2004WO2004089978A2 Use of hcv proteins
10/21/2004WO2004089976A1 Method of treatment
10/21/2004WO2004089422A2 Methods of treating and monitoring systemic lupus erythematosus in individuals
10/21/2004WO2004089417A1 Drug-enclosing multilayer structure particulate and process for producing the same
10/21/2004WO2004089413A1 Nucleotide and cellular vaccine composition
10/21/2004WO2004089407A2 Zwitterionic immunomodulators for the treatment of asthma and allergy
10/21/2004WO2004089406A1 Topical composition in the form of a gel for treating skin burns
10/21/2004WO2004089405A1 Therapeutic composition for autoimmune conditions
10/21/2004WO2004089404A1 Hemoglobin conjugate and the preparation method and its use
10/21/2004WO2004089403A1 Method of removing albumin aggregate and/or contaminated protein
10/21/2004WO2004089402A1 Process for producing albumin preparation
10/21/2004WO2004089401A1 Remedy for ischemia
10/21/2004WO2004089400A1 Remedy for cardiomyopathy
10/21/2004WO2004089399A1 Novel uses of rfrp and ot7t022
10/21/2004WO2004089398A1 Fungal vacuolar proteins as a target for antifugal agents
10/21/2004WO2004089396A2 Anti-fungal peptidomimetics
10/21/2004WO2004089395A2 Use of an inhibitor of cathepsin-s or -b to treat or prevent chronic obstructive pulmonary disease
10/21/2004WO2004089394A2 Treatment of severe acute respiratory syndrome (sars)
10/21/2004WO2004089388A1 The ready-prepared chinese medicine for treatment of hair loss and process of manufacturing thereof
10/21/2004WO2004089376A2 Identification and targeting of consensus sites by which dynorphin exerts its neurotoxic effects enables analgesia without neurotoxicity
10/21/2004WO2004089354A2 Peptides and derivatives thereof as inhibitors of oxidative-induced degradation phenomena and compositions containing them
10/21/2004WO2004089335A2 Non-aqueous single phase vehicles and formulations utilizing such vehicles
10/21/2004WO2004089297A2 Compounds and methods for treatment of thrombosis
10/21/2004WO2004089296A2 Improved inhibitors for the soluble epoxide hydrolase
10/21/2004WO2004089290A2 Novel probiotic compositions and methods of using the same
10/21/2004WO2004089283A2 Compositions and methods for treating viral infections
10/21/2004WO2004089280A2 Reversible pegylated drugs
10/21/2004WO2004089279A2 Long-acting derivatives of pyy agonists
10/21/2004WO2004089278A2 Sexual hygienic composition
10/21/2004WO2004089097A1 Composition with heart rate reducing properties
10/21/2004WO2004081024A3 Anti-microbial peptide known as halocyntin, gene coding for said peptide, vector, transformed organism and composition containing said peptide
10/21/2004WO2004073650A3 Peptidomimetic inhibitors of stat3 activity and their medical uses
10/21/2004WO2004072305A3 Atlastin
10/21/2004WO2004067026A8 Regulation of allergen induced gene
10/21/2004WO2004064860A8 Use of tff2, or agents inducing tff2, in the therapy of allergies
10/21/2004WO2004064856A3 Proteins involved in the regulation of energy homeostasis
10/21/2004WO2004062556A8 Methods for preventing and treating alzheimer’s disease (ad)
10/21/2004WO2004060312A3 Topical composition and methods for treatment of aged or environmentally damaged skin
10/21/2004WO2004058287A8 Methods of treating neurological conditions with hematopoeitic growth factors
10/21/2004WO2004056871A3 Peptides and their use for the treatment of hiv infections
10/21/2004WO2004052389A3 Nogo, caspr, f3 nb-3 useful in the treatment of injury and disease to the central nervous system
10/21/2004WO2004047765A3 Compositions, methods, and kits for weight loss and inhibiting the loss of lean body mass
10/21/2004WO2004045542A3 Therapeutic bioconjugates
10/21/2004WO2004044222A3 Polymeric prodrugs of vancomycin
10/21/2004WO2004043428A3 Buccal, polar and non-polar spray or capsule containing drugs for treating pain
10/21/2004WO2004042025A3 Cell-specific adenovirus vector comprising ebv-specific promoter
10/21/2004WO2004039315A3 Method for treating wounds to promote healing
10/21/2004WO2004034971A3 Methods for treating and preventing sepsis using modified c1 inhibitor or fragments thereof
10/21/2004WO2004028468A3 Methods and compositions for treatment of neurological disorder
10/21/2004WO2004010939A3 Methods of using non-human animal apoliprotein a-i protein
10/21/2004WO2004003134A3 Antisense inhibition via rnase h-independent reduction in mrna
10/21/2004WO2003102197A8 Transgenic plants with controlled distribution of a trait to progeny
10/21/2004WO2003100081A3 Biologically active maleamic acid derivatives with labile amide bonds
10/21/2004WO2003099849A3 Use of a parathyroid hormone peptide analogs for the treatment of vaginal atrophy
10/21/2004WO2003093793A3 Binary or polynary targeting and uses thereof
10/21/2004WO2003045228A3 Methods for treating autoimmune disorders, and reagents related thereto
10/21/2004WO2003043631A3 Method for identification of tumor targeting enzymes
10/21/2004WO2003027266A3 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
10/21/2004WO2003026490A3 Methods and compositions for prevention, diagnosis, and treatment of cancer using bispecific molecules
10/21/2004WO2003025142A3 Novel nucleic acids and secreted polypeptides
10/21/2004WO2003025120A3 Clasp membrane proteins
10/21/2004WO1995027066A9 Dna encoding ubiquitin conjugating enzymes
10/21/2004US20040210950 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (CALSARCINS)
10/21/2004US20040210059 Carboxylic acids, optionally in the form of amino acids, react with chloroformates to yield intermediates, which react with amines
10/21/2004US20040210039 Keratin-based products and methods for their productions
10/21/2004US20040210037 Comprises major histocompatibility complex fusion protein for use in treating and/or preventing cancer, infection, allergies and autoimmune diseases
10/21/2004US20040210035 Major histocompatibility complex epitope peptides for detection and treatment of cell proliferative disorders
10/21/2004US20040209941 administering inhibitor of the renin-angiotensin system such as quinapril; for AIDS patients under retroviral therapy
10/21/2004US20040209866 1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders
10/21/2004US20040209840 Manipulation of arterial-venous identity
10/21/2004US20040209839 Human peroxisome proliferator activated receptor gamma
10/21/2004US20040209838 Antisense oligonucleotide which inhibits gene coding diacylglycerol acyltransferase for use in diagnosis, prevention and treatment of abnormal cholesterol, hyperlipidemia, diabetes, obesity and cardiovascular disease
10/21/2004US20040209837 Vascularization inhibitors
10/21/2004US20040209836 activation of antigen-presenting cells; modifying dendritic cells to express an inducible form of a co-stimulatory polypeptide molecule; used to bolster the immune response of an immunocompromised subject, such as an HIV-infected subject
10/21/2004US20040209834 mouse double minute (MDM); determining the mdm2-dependent growth activity of a cell by introducing vectors for expressing a p53 polypeptide or fragment into the cell, and measuring the growth of the cell
10/21/2004US20040209832 RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
10/21/2004US20040209831 RNA interference mediated inhibition of hepatitis C virus (HCV) gene expression using short interfering nucleic acid (siNA)
10/21/2004US20040209829 Oral treatment of hemophilia
10/21/2004US20040209820 dipeptides/tripeptides; for attenuation of neuropeptide Y mediated responses; sustained release; biodegradable
10/21/2004US20040209819 Administering to the chronic skin ulcer an effective amount of a polypeptide of between 14 to 23 amino acids in length, cotnains a thrombin receptor binding domain of the sequence Arg-Gly-Asp-Ala (SEQ ID NO.: 7) and a serine esterase conserved sequence
10/21/2004US20040209818 Immunomodulating polymers
10/21/2004US20040209817 Methods and compositions for the treatment of peripheral artery disease
10/21/2004US20040209816 Treatment for diabetes
10/21/2004US20040209815 Compositions providing for increased IGF-I solubility
10/21/2004US20040209814 method for maximal parenteral nutrition substantially without acute or chronic hyperglycemia; includes a source of nutrients (carbohydrates) and an insulinotropic peptide (Glucagon-like-peptides, exendin)
10/21/2004US20040209813 Caspase inhibitors for inhibiting blood cell proliferation and for treating autoimmune diseases
10/21/2004US20040209812 Use of erythropoietin in stroke recovery
10/21/2004US20040209811 comprising water-soluble formula and/or enteric-coated formula (C-phycocyanin, allophycocyanin, spirulina growth factor)
10/21/2004US20040209810 administering transforming/nerve growth factors to putamen via catheter connected to inflatable pump; increasing dopaminergic neurons; drug delivery kits
10/21/2004US20040209809 Shc modulation and uses thereof
10/21/2004US20040209808 antiproliferative agents; monoclonal/polyclonal antibodies; drug screening; kits
10/21/2004US20040209807 Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity
10/21/2004US20040209806 controlling trefoil factor-2 (TFF2) expression; for reducing acid secretion and/or increasing epithelial cell proliferation to promote healing; lung assessment
10/21/2004US20040209805 such as fibrosis via activin antagonist (fullistatin); kits; gene therapy; treating inflammatory bowel disease and crohn's disease
1 ... 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 ... 3163